$141 Million is the total value of Michelson Medical Research Foundation, Inc.'s 20 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HYG | ISHARES TRiboxx hi yd etf | $19,152,609 | -0.6% | 255,130 | 0.0% | 13.63% | -9.8% | |
| VEA | VANGUARD TAX-MANAGED FDSvan ftse dev mkt | $14,125,308 | +2.2% | 305,875 | 0.0% | 10.05% | -7.2% | |
| BKLN | INVESCO EXCH TRADED FD TR IIsr ln etf | $12,636,834 | +1.2% | 600,610 | 0.0% | 8.99% | -8.2% | |
| BSV | VANGUARD BD INDEX FDSshort trm bond | $12,457,337 | -1.2% | 164,845 | 0.0% | 8.86% | -10.4% | |
| VWO | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $9,626,108 | +0.7% | 236,630 | 0.0% | 6.85% | -8.6% | |
| AVB | AVALONBAY CMNTYS INC | $8,419,676 | +12.6% | 44,485 | 0.0% | 5.99% | +2.2% | |
| IVE | ISHARES TRs&p 500 val etf | $8,366,567 | +6.2% | 51,905 | 0.0% | 5.95% | -3.6% | |
| IVV | ISHARES TRcore s&p500 etf | $8,017,877 | +8.4% | 17,989 | 0.0% | 5.70% | -1.6% | |
| HDV | ISHARES TRcore high dv etf | $7,381,860 | -0.9% | 73,240 | 0.0% | 5.25% | -10.0% | |
| IBB | ISHARES TRishares biotech | $5,509,429 | -1.7% | 43,395 | 0.0% | 3.92% | -10.8% | |
| PLD | PROLOGIS INC. | $5,200,125 | -1.7% | 42,405 | 0.0% | 3.70% | -10.8% | |
| ARE | ALEXANDRIA REAL ESTATE EQ IN | $4,225,233 | -9.6% | 37,230 | 0.0% | 3.01% | -18.0% | |
| CRC | CALIFORNIA RES CORP | $2,647,201 | +17.6% | 58,450 | 0.0% | 1.88% | +6.7% | |
| XBI | SPDR SER TRs&p biotech | $2,604,160 | +9.2% | 31,300 | 0.0% | 1.85% | -0.9% | |
| PFF | ISHARES TRpfd and incm sec | $2,535,332 | -0.9% | 81,970 | 0.0% | 1.80% | -10.1% | |
| TALO | TALOS ENERGY INC | $1,938,749 | -6.5% | 139,780 | 0.0% | 1.38% | -15.2% | |
| CRESCENT ENERGY COMPANY | $1,627,250 | -7.9% | 156,166 | 0.0% | 1.16% | -16.4% | ||
| BXP | BOSTON PROPERTIES INC | $1,251,719 | +6.4% | 21,735 | 0.0% | 0.89% | -3.4% | |
| NML | NEUBERGER BERMAN ENERGY INFR | $797,199 | +4.7% | 115,872 | 0.0% | 0.57% | -5.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 4 | Q3 2023 | 15.1% |
| VANGUARD TAX-MANAGED FDS | 4 | Q3 2023 | 10.8% |
| VANGUARD BD INDEX FDS | 4 | Q3 2023 | 9.9% |
| INVESCO EXCH TRADED FD TR II | 4 | Q3 2023 | 9.8% |
| VANGUARD INTL EQUITY INDEX F | 4 | Q3 2023 | 7.5% |
| ISHARES TR | 4 | Q3 2023 | 8.7% |
| ISHARES TR | 4 | Q3 2023 | 8.4% |
| ISHARES TR | 4 | Q3 2023 | 8.9% |
| AVALONBAY CMNTYS INC | 4 | Q3 2023 | 6.0% |
| ISHARES TR | 4 | Q3 2023 | 4.4% |
View Michelson Medical Research Foundation, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
View Michelson Medical Research Foundation, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.